Masana, L, Correig, E, Rodriguez-Borjabad, C, Anoro, E, Arroyo, JA, Jerico, C, Pedragosa, A, la Miret, M, Naf, S, Pardo, A, Perea, V, Perez-Bernalte, R, Plana, N, Ramirez-Montesinos, R, Royuela, M, Soler, C, Urquizu-Padilla, M, Zamora, A, Pedro-Botet, J. Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients. European Heart Journal-Cardiovascular Pharmacotherapy. 2022; 8(2)DOI:10.1093/ehjcvp/pvaa128. PMID:33135047. IF:7.100(Q1/1D).

Tornero-Molina, J, Alperi-Lopez, M, Castellvi, I, de Agustin-de Oro, JJ, Escudero, A, Garcia-Vicuna, R, Gonzalez-Gay, MA, Hidalgo, C, Rubio, E, Sanmarti, R, Casamira, N, Calvo-Alen, J. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis. Reumatologia Clinica. 2022; 18(1)DOI:10.1016/j.reuma.2020.08.003. PMID:35090610. IF:(Q/D).

Ortiz, MA, Diaz-Torne, C, De Agustin, JJ, Estrada, P, Reina, D, Hernandez, MV, Sang, HY, Zamora, C, Canto, E, Corominas, H, Vidal, S. Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response. Biomolecules. 2024; 14(1)DOI:10.3390/biom14010001. PMID:38275742. IF:4.800(Q1/3D).

Molina, JT, Hernández-Cruz, B, Corominas, H. Initial Treatment with Biological Therapy in Rheumatoid Arthritis. Journal of Clinical Medicine. 2024; 13(1)DOI:10.3390/jcm13010048. PMID:38202055. IF:2.900(Q1/2D).

Balsa A., Díaz del Campo Fontecha P., Silva Fernández L., Valencia Martín J., Nistal Martínez V., León Vázquez F., Hernández Hernández M.V., Corominas H., Cáliz Cáliz R., Aguado García J.M., Candelas Rodríguez G., Ibargoyen Roteta N., Martí Carbajal A., Plana Farras M.N., Puñal Riobóo J., Park H.S., Triñanes Pego Y., Villaverde García V.. Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis. Reumatologia Clinica. 2023; 19(10)DOI:10.1016/j.reuma.2023.07.001. PMID:. IF:(Q/D).

Sainz, L, Riera, P, Moya, P, Bernal, S, Casademont, J, Diaz-Torne, C, Millan, AM, Park, HS, Lasa, A, Corominas, H. Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis. ARTHRITIS RESEARCH & THERAPY. 2023; 25(1)DOI:10.1186/s13075-023-03209-1. PMID:38001504. IF:4.400(Q1/3D).

Valero-Martínez, C, Urgelles, JF, Sallés, M, Joven-Ibáñez, BE, de Juanes, A, Ramírez, J, Juanola, X, Almodóvar, R, Laiz, A, Moreno, M, Pujol, M, Beltrán, E, Pinto-Tasende, JA, Crespí, L, Sala-Icardo, L, Castañeda, S, García-Vicuña, R. Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1283251. PMID:37936691. IF:5.700(Q1/3D).

Osuna-Gomez, R, Castellvi, I, Mulet, M, Ortiz, MA, Brough, DE, Sabzevari, H, Semnani, RT, Vidal, S. Impaired Regulation by IL-35 in Systemic Sclerosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13)DOI:10.3390/ijms241310567. PMID:37445745. IF:4.900(Q1/3D).

De Miguel, E, Sanchez-Costa, JT, Estrada, P, Munoz, A, Martinez, CV, Alvarado, PM, Garcia-Villanueva, MJ, Angeles, VAN, Da Veiga, CGL, Frutos, AR, Ivorra, JAR, Arrabal, SL, Rocha, MV, Iniguez, CL, Garcia-Gonzalez, M, Molina-Almela, C, Villar, MA, Mas, AJ, Gonzalez-Gay, MA, Blanco, R. Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register (vol 8, e002507, 2022). RMD Open. 2023; 9(2)DOI:10.1136/rmdopen-2022-002507corr1. PMID:. IF:5.100(Q1/2D).

Morillon, MB, Norup, A, Singh, JA, Dalbeth, N, Taylor, WJ, Kennedy, MA, Pedersen, BM, Grainger, R, Tugwell, P, Perez-Ruiz, F, Diaz-Torne, C, Edwards, NL, Shea, B, Ellingsen, TJ, Christensen, R, Stamp, LK. Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023; 60DOI:10.1016/j.semarthrit.2023.152191. PMID:36963128. IF:4.600(Q1/2D).

Díaz-Torné C., Pou M.A., Rodríguez-Díez B., Pujol-Ribera E.. Living with gout. Experiences, impact and challenges of the disease. Qualitative study through focus groups. Reumatologia Clinica. 2023; 19(3)DOI:10.1016/j.reuma.2022.03.009. PMID:36058814. IF:(Q/D).

Sanmarti, R, Corominas, H. Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review. Journal of Clinical Medicine. 2023; 12(5)DOI:10.3390/jcm12051734. PMID:36902522. IF:3.000(Q1/2D).

Hernández-de Sosa N., Cardona Corrales R., Casademont J.. A 37-Year-Old Man with Familial Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations Presenting with Seizures and a Diagnosis of Brain Abscesses. AMERICAN JOURNAL OF CASE REPORTS. 2023; 24DOI:10.12659/AJCR.938548. PMID:36841939. IF:(Q/D).

Sainz L., Riera P., Moya P., Bernal S., Casademont J., Díaz-Torné C., Millán A.M., Park H.S., Lasa A., Corominas H.. Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of Personalized Medicine. 2023; 13(1)DOI:10.3390/jpm13010061. PMID:36675722. IF:3.000(Q1/2D).

Colalillo A., Hoffmann-Vold A.-M., Pellicano C., Romaniello A., Gabrielli A., Hachulla E., Smith V., Simeón-Aznar C.-P., Castellví I., Airò P., Truchetet M.-E., Siegert E., Distler O., Rosato E.. The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort. AUTOIMMUNITY REVIEWS. 2023; 22(4)DOI:10.1016/j.autrev.2023.103290. PMID:36746368. IF:9.200(Q1/1D).

Queiro R., Seoane-Mato D., Laiz A., Galindez Agirregoikoa E., Montilla C., Park H.S., Tasende J.A.P., Baute J.J.B., Joven Ibáñez B., Toniolo E., Ramírez J., Montero N., Pruenza García-Hinojosa C., Serrano García A.. Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning. Journal of Clinical Medicine. 2023; 12(3)DOI:10.3390/jcm12030931. PMID:36769579. IF:3.000(Q1/2D).

Jeria-Navarro S., Gomez-Gomez A., Park H.S., Calvo-Aranda E., Corominas H., Pou M.A., Diaz-Torne C.. Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature. Frontiers in Medicine. 2023; 9DOI:10.3389/fmed.2022.1089993. PMID:36714095. IF:3.100(Q1/2D).

Narváez J., Aburto M., Seoane-Mato D., Bonilla G., Acosta O., Candelas G., Cano-Jiménez E., Castellví I., González-Ruiz J.M., Corominas H., López-Muñiz B., Martín-López M., Robles-Pérez A., Mena-Vázquez N., Rodríguez-Portal J.A., Ortiz A.M., Sabater-Abad C., Castrejón I., dos Santos R., Garrote-Corral S., Maese J., Silva-Fernández L., Castañeda S., Valenzuela C.. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology. Reumatologia Clinica. 2023; 19(2)DOI:10.1016/j.reuma.2021.12.006. PMID:35753951. IF:(Q/D).

Queiro R., Seoane-Mato D., Laiz A., Agirregoikoa E.G., Montilla C., Park H.S., Pinto-Tasende J.A., Bethencourt Baute J.J., Ibáñez B.J., Toniolo E., Ramírez J., Marcos A.G.. Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023; 41(1)DOI:10.55563/clinexprheumatol/077ul6. PMID:35699067. IF:3.400(Q2/3D).

Oteo J.A., Corominas H., Escudero R., Fariñas-Guerrero F., García-Moncó J.C., Goenaga M.A., Guillén S., Mascaró J.M., Portillo A.. Executive summary of the consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Society of Neurology (SEN), Spanish Society of Immunology (SEI), Spanish Society of Pediatric Infectology (SEIP), Spanish Society of Rheumatology (SER), and Spanish Academy of Dermatology and Venereology (AEDV), on the diagnosis, treatment and prevention of Lyme borreliosis. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2023; 41(1)DOI:10.1016/j.eimc.2022.03.004. PMID:36621247. IF:2.600(Q3/6D).

Corominas H., Young D., Cummings J.R.F., Bouhnik Y., Armuzzi A., Thaci D., Kim J.. Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review. CLINICAL DRUG INVESTIGATION. 2023; 43(8)DOI:10.1007/s40261-023-01284-5. PMID:37615857. IF:(Q/D).

Casademont J.. Physical examination today. MEDICINA CLINICA. 2023; 160(12)DOI:10.1016/j.medcli.2023.02.001. PMID:36907715. IF:2.600(Q1/3D).

Tandaipan J, Guillén-Del-Castillo A, Simeón-Aznar CP, Carreira PE, De la Puente C, Narváez J, Lluch J, Rubio-Rivas M, Alegre-Sancho JJ, Bonilla G, Moriano C, Casafont-Sole I, García-Vicuña R, Ortiz-Santamaría V, Riera E, Atienza-Mateo B, Blanco R, Galisteo C, Gonzalez-Martin JJ, Pego-Reigosa JM, Pros A, Heredia S, Castellví I. Immunoglobulins in systemic sclerosis management. A large multicenter experience.. AUTOIMMUNITY REVIEWS. 2023; 22(11)DOI:10.1016/j.autrev.2023.103441. PMID:37708984. IF:9.200(Q1/1D).

De Miguel, E, Sanchez-Costa, JT, Estrada, P, Munoz, A, Martinez, CV, Alvarado, PM, Garcia-Villanueva, MJ, Angeles, VAN, Da Veiga, CGL, Frutos, AR, Ivorra, JAR, Arrabal, SL, Rocha, MV, Iniguez, CL, Garcia-Gonzalez, M, Molina-Almeda, C, Villar, MA, Mas, AJ, Gonzalez-Gay, MA, Blanco, R. Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register. RMD Open. 2022; 8(2)DOI:10.1136/rmdopen-2022-002507. PMID:36597988. IF:6.200(Q1/2D).

Martin-Varillas, JL, Sanchez-Bilbao, L, Calvo-Rio, V, Adan, A, Hernanz, I, Gallego-Flores, A, Beltran-Catalan, E, Castro-Oreiro, S, Fanlo, P, Martos, AG, Torre, I, Cordero-Coma, M, De Dios, JR, Garcia-Aparicio, A, Hernandez-Garfella, M, Sanchez-Andrade, A, Garcia-Valle, A, Maiz, O, Miguelez, R, Rodriguez-Montero, S, Urruticoechea, A, Veroz, R, Conesa, A, Fernandez-Carballido, C, Jovani, V, Mondejar, JJ, Gonzalez, OM, Alvarado, PM, Romero-Yuste, S, Rubio-Munoz, P, Pena-Sainz-Pardo, E, Garijo-Bufort, M, Demetrio-Pablo, R, Hernandez, JL, Blanco, R. Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients. RMD Open. 2022; 8(2)DOI:10.1136/rmdopen-2022-002693. PMID:36597972. IF:6.200(Q1/2D).

Vilchez-Oya, F, Martin, HB, Garcia-Martinez, E, Corominas, H. Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjogren's syndrome: A critical review. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.1003054. PMID:36325321. IF:7.300(Q1/3D).

Hemmig, AK, Gozzoli, D, Werlen, L, Ewald, H, Aschwanden, M, Blockmans, D, Brouwer, E, Buchanan, RRC, Camellino, D, Campochiaro, C, Cimmino, MA, Corominas, H, Gloy, V, Henckaerts, L, Kyburz, D, Moya-Alvarado, P, Owen, CE, Stegert, M, Tomelleri, A, van Sleen, Y, Yamashita, H, Imfeld, S, Berger, CT, Hemkens, LG, Daikeler, T. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022; 55DOI:10.1016/j.semarthrit.2022.152017. PMID:35537222. IF:5.000(Q2/3D).

Zozaya N., Arrizubieta Basterrechea M.I., Bollo E., Castellví I., Espín J., Ortego N., Poveda-Andrés J.L., Rodríguez Portal J.A., Rivero A., Marcos-Rodríguez J.A., Verde L.. A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2022; 38(1)DOI:10.1017/S0266462322000459. PMID:35912833. IF:3.200(Q2/5D).

Calvo, JIP, Pou, JCI. Continuing medical education. An opportunity to continue improving. MEDICINA CLINICA. 2022; 159(1)DOI:10.1016/j.medcli.2022.03.012. PMID:35636993. IF:3.900(Q2/4D).

Queiro R., Seoane-Mato D., Laiz A., Agirregoikoa E.G., Montilla C., Park H.-S., Pinto-Tasende J.A., Baute J.J.B., Ibáñez B.J., Toniolo E., Ramírez J., García A.S.. Characteristics associated with the perception of high-impact disease (PsAID =4) in patients with recent-onset psoriatic arthritis. Machine learning-based model. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022; 57DOI:10.1016/j.semarthrit.2022.152097. PMID:36113222. IF:5.000(Q2/3D).

Kerick M., Acosta-Herrera M., Simeón-Aznar C.P., Callejas J.L., Assassi S., Carreira P., Castellvi I., Ríos R., Portales R.G., Fernández-Nebro A., García-Hernández F.J., Aguirre M.A., Fernández-Gutiérrez B., Rodríguez-Rodríguez L., de la Peña P.G., Vicente E., Andreu J.L., de Castro M.F., López-Longo F.J., Fonollosa V., Guillén A., Tolosa C., Pros A., Beltrán E., Carballeira M.R., Narváez F.J., Rivas M.R., Ortiz-Santamaría V., Madroñero A.B., González-Gay M.A., Díaz B., Trapiella L., Egurbide M.V., Fanlo-Mateo P., Saez-Comet L., Díaz F., Roman-Ivorra J.A., Sancho J.J.A., Freire M., Garcia F.J.B., Oreiro N., Kreuter A., Riemekasten G., Airò P., Magro C., Voskuyl A.E., Vonk M.C., Hesselstrand R., Nordin A., Lunardi C., Gabrielli A., Hoffmann-Vold A., Distler J.H.W., Padyukov L., Koeleman B.P.C., Proudman S.M., Nikpour M., Stevens W., Zochling J., Sahhar J., Roddy J., Nash P., Tymms K., Rischmueller M., Lester S., Vigone B., Pers J.-O., Saraux A., Devauchelle-Pensec V., Cornec D., Jousse-Joulin S., Lauwerys B., Ducreux J., Maudoux A.-L., Vasconcelos C., Tavares A., Neves E., Faria R., Brandão M., Campar A., Marinho A., Farinha F., Almeida I., Mantecón M.A.G.-G., Alonso R.B., Martínez A.C., Cervera R., Rodríguez-Pintó I., Espinosa G., Lories R., De Langhe E., Belz D., Witte T., Baerlecken N., Stummvoll G., Zauner M., Lehner M., Collantes E., Ortega-Castro R., Aguirre-Zamorano M.A., Escudero-Contreras A., Castro-Villegas M.C., Roldán M.C.F., Ortego N., Raya E., Moleón I.J., de Ramon E., Quintero I.D., Meroni P.L., Gerosa M., Schioppo T., Artusi C., Chizzolini C., Zuber A., Wynar D., Kovács L., Balog A., Deák M., Bocskai M., Dulic S., Kádár G., Hiepe F., Gerl V., Thiel S., Maresca M.R., López-Berrio A., Aguilar-Quesada R., Navarro-Linares H., Hunzelmann N., Moroncini G., de Vries-Bouwstra J.K., Orozco G., Barton A., Herrick A.L., Terao C., Allanore Y., Fonseca C., Alarcón-Riquelme M.E., Radstake T.R.D.J., Beretta L., Denton C.P., Mayes M.D., Martin J.. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis. npj Genomic Medicine. 2022; 7(1)DOI:10.1038/s41525-022-00327-8. PMID:36198672. IF:5.300(Q1/2D).

Queiro R., Seoane-Mato D., Laiz A., Agirregoikoa E.G., Montilla C., Park H.-S., Pinto-Tasende J.A., Bethencourt Baute J.J., Ibáñez B.J., Toniolo E., Ramírez J., García A.S., Cañete J.D., Juanola X., Fiter J., Gratacós J., Rodriguez-Moreno J., Rosa J.N., Martín A.L., García A.B., Segura P.C., Ferrer A.L., Barrio S.P., Plata Izquierdo A.J., Bustabad S., Guimerá Martín-Neda F.J., Capdevilla E.F., Díaz R.R., Cuervo A., Gibert M.A., Larraz P.T., de la Morena Barrio I., Lanza L.P., Sanchís D.B., Mesquida C.M., Murillo C., Moreno Ramos M.J., Beteta M.D., Guillén P.S.-P., Oliveira L.L., Marco T.N., Cebrián L., de la Cueva Dobao P., Steiner M., Muñoz-Fernández S., Garrido R.V., León M., Rubio E., Jiménez A.M., Fernández-Freire L.R., Luezas J.M., Sánchez-González M.D., Muñoz C.S., Senabre J.M., Rosas J.C., Soler G.S., Mataix Díaz F.J., Nieto-González J.C., González C., Ovalles Bonilla J.G., Rodríguez O.B., Medina F.J.N., Luján D., Ruiz Montesino M.D., Carrizosa Esquivel A.M., Fernández-Carballido C., Martínez-Vidal M.P., Fernández L.G., Jovani V., Alameda R.C., Sabater S.G., Romero I.B., Urruticoechea-Arana A., Torres M.S., Almodóvar R., López Estebaranz J.L., López Montilla M.D., García-Nieto A.V.. Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning. ARTHRITIS RESEARCH & THERAPY. 2022; 24(1)DOI:10.1186/s13075-022-02838-2. PMID:35751091. IF:4.900(Q2/4D).

Kuster S., Jordan S., Elhai M., Held U., Steigmiller K., Bruni C., Cacciapaglia F., Vettori S., Siegert E., Rednic S., Codullo V., Airo P., Braun-Moscovici Y., Hunzelmann N., Joao Salvador M., Riccieri V., Gheorghiu A.-M., Alegre Sancho J.J., Romanowska-Prochnicka K., Castellví I., Kötter I., Truchetet M.-E., López-Longo F.J., Novikov P.I., Giollo A., Shirai Y., Belloli L., Zanatta E., Hachulla E., Smith V., Denton C., Ionescu R.M., Schmeiser T., Distler J.H.W., Gabrielli A., Hoffmann-Vold A.-M., Kuwana M., Allanore Y., Distler O.. Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD Open. 2022; 8(2)DOI:10.1136/rmdopen-2022-002477. PMID:36328401. IF:6.200(Q1/2D).

Balsa A., González-Álvaro I., Sanmartí R., Corominas H.. How do Spanish Rheumatologists handle remission? Survey of knowledge and approach before and after a training workshop. Reumatologia Clinica. 2022; 18(9)DOI:10.1016/j.reuma.2021.08.002. PMID:34489191. IF:(Q/D).

Narváez J., Díaz del Campo Fontecha P., Brito García N., Bonilla G., Aburto M., Castellví I., Cano-Jiménez E., Mena-Vázquez N., Nieto M.A., Ortiz A.M., Valenzuela C., Abad Hernández M.Á., Castrejón I., Correyero Plaza M., Francisco Hernández F.M., Hernández Hernández M.V., Rodríquez Portal J.A.. SER-SEPAR recommendations for the the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment. Reumatologia Clinica. 2022; 18(9)DOI:10.1016/j.reuma.2022.03.005. PMID:36064885. IF:(Q/D).

Rodríguez Portal J.A., Brito García N., Díaz del Campo Fontecha P., Valenzuela C., Ortiz A.M., Nieto M.A., Mena-Vázquez N., Cano-Jiménez E., Castellví I., Aburto M., Bonilla G., Hernández Hernández M.V., Hernández F.M.F., Correyero Plaza M., Castrejón I., Abad Hernández M.Á., Narváez J.. SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis. Reumatologia Clinica. 2022; 18(8)DOI:10.1016/j.reuma.2022.02.009. PMID:36085196. IF:(Q/D).

Hernández-Cruz B., Rosas J., Díaz-Torné C., Belzunegui J., García-Vicuña R., Inciarte-Mundo J., Pons A., Millán A.M., Jeria-Navarro S., Valero J.A., García-Castañeda N., Valero C., Llorente I., Calvo A., Díaz-Cerezo S., Núñez M.. Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study) (Rheumatology and Therapy, (2022), 9, 2, (589-608), 10.1007/s40744-021-00423-8). Rheumatology and Therapy. 2022; 9(4)DOI:10.1007/s40744-022-00463-8. PMID:35653064. IF:3.800(Q3/6D).

Cobo-Ibáñez T., Sánchez-Piedra C., Nuño-Nuño L., Castellví I., Carrión-Barberà I., Romero-Bueno F., Narváez J., Trallero-Araguás E., Tomero E., Ruiz-Lucea M.E., Larena C., Carrasco Cubero C., Jovaní V., Barbadillo C., Sivera F., Belzunegui J., Pérez Gómez A., Gómez Gómez A., Delgado-Frías E., Pego-Reigosa J.M., Joven B., Ibáñez M., Martínez-González O., Ruiz-Román A., Camins J., Ortega-Castro R., Trenor Larra P., Rodríguez López M., Freire M., Alcocer P., Holgado S., Rúa-Figueroa I., Lozano N., Martínez-Barrio J.. Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology. Reumatologia Clinica. 2022; 18(5)DOI:10.1016/j.reuma.2021.01.007. PMID:33867271. IF:(Q/D).

Queiro R., Seoane-Mato D., Laiz A., Galindez Agirregoikoa E., Montilla C., Park H.S., Pinto Tasende J.A., Bethencourt Baute J.J., Joven Ibáñez B., Toniolo E., Ramírez J., Pruenza García-Hinojosa C.. Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.891863. PMID:35572968. IF:3.900(Q2/4D).

Mir-Perelló C., López B.M., Pérez B.S., Torrent R.B., Fernández M.I.G., Corbeto M.L., Gil J.G., Zavala R.G.. Recomendaciones para el diagnóstico y tratamiento de la baja masa ósea para la edad cronológica y la osteoporosis infantil en Atención Primaria. Pediatria De Atencion Primaria. 2022; 24(94)DOI:. PMID:. IF:(Q/D).